Guanfacine Hydrochloride Tablet
Product Images NDC 50268-374

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Guanfacine Hydrochloride (NDC 50268-374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 5026837315 Guanfacine 2018 1mg

Guanfacine is a medication available in tablet form that is used for the treatment of hypertension and attention deficit hyperactivity disorder (ADHD). Each tablet contains 1mg of Guanfacine hydrochloride, USP equivalent to quantacine. It is important to store the medication at temperatures between 20°C and 25°C (68°F and 77°F) and to keep it out of the reach of children. Usual dosage should be determined by a healthcare provider, and complete information can be found in the package insert. This medication is produced by AVKARE, Inc.*

FDA Label Image

3 (Screen Shot 2017 06 07 At 1.49.59 Pm)

Guanfacine is a medication available in tablet form that is only available with a prescription. Each blister pack has 5 units of 10 tablets each. The tablets contain Guanfacine hydrochloride, USP equivalent to 2 mg and are used as per the instructions given on the package. The medication should be stored between 20° to 25°C (68° to 77°F) and kept out of reach of children. AVKARE, Inc. manufactures Guanfacine for medical use.*

FDA Label Image

042bf3b6-figure-01 (Guanfacine Tablets Usp 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.